Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies
Diverse FcγR-dependent mechanisms mediate anticancer activity of proapoptotic and immunomodulatory antibodies.
Main Authors: | Kim, Jeong M., Ashkenazi, Avi |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754862/ |
Similar Items
-
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors
by: Isoda, Yuya, et al.
Published: (2015) -
Universal Antibody Conjugation to Nanoparticles Using
the Fcγ Receptor I (FcγRI): Quantitative Profiling Of
Membrane Biomarkers
by: Kim, Chloe, et al.
Published: (2014) -
Fcγ receptor targeting in RA
by: Takai, Toshiyuki, et al.
Published: (2012) -
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
by: Stopforth, Richard J., et al.
Published: (2016) -
Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors
by: Borlak, Jürgen, et al.
Published: (2016)